Children to get CRISPR treatment for sickle cell disease in trial
CRISPR gene-editing trials for treating beta thalassaemia and sickle cell disease are being extended to include people under the age of 12 after positive results in older people
Landwebs
0
1
CRISPR gene-editing trials for treating beta thalassaemia and sickle cell disease are being extended to include people under the age of 12 after positive results in older people
